Literature DB >> 24555614

Total artificial heart implantation: clinical indications, expected postoperative imaging findings, and recognition of complications.

Mark S Parker1, Lester J Fahrner, Brian P F Deuell, Kathryn M Olsen, Vigneshwar Kasirajan, Keyur B Shah, Angel E Medina, Kelly R Doolin, Patricia M de Groot, Patti Ann de Groot, William C Goodman.   

Abstract

OBJECTIVE: The purposes of this article are to review the treatment options for late-stage biventricular heart failure, discuss the clinical indications for total artificial heart (TAH) implantation, illustrate the expected imaging findings after uncomplicated TAH implantation, and highlight the radiologic findings of common and uncommon complications associated with TAH implantation through case examples.
CONCLUSION: TAH implantation is an effective therapeutic option for the treatment of patients with end-stage biventricular heart failure. The duration of implantation varies depending on a particular patient's medical condition and the eventual availability of a human heart for orthotopic transplantation. TAH recipients often undergo imaging with conventional radiography, CT, or both for the assessment of device-related issues, many of which are life-threatening and require emergency management. As the clinical use of the TAH increases and becomes more commonplace, it is imperative that radiologists interpreting imaging studies recognize both the expected and the unexpected imaging findings that affect patient care.

Entities:  

Mesh:

Year:  2014        PMID: 24555614     DOI: 10.2214/AJR.13.11066

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Heart and Kidney Transplant in a Patient on Total Artificial Heart Bridge Therapy for 318 Days.

Authors:  Sunny S Cai; Heather L Andrews; Christopher A Molini
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-01-31

2.  Airway Complications of Total Artificial Heart.

Authors:  Vikas Pathak; Colin Donovan; Rajiv Malhotra
Journal:  Indian J Crit Care Med       Date:  2017-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.